Literature DB >> 27831603

[Medication use among older adults in Bogota, Colombia].

Carlos Cano-Guitierrez1, Rafael Samper-Ternent1, Javier Cabrera1, Diego Rosselli1.   

Abstract

OBJECTIVES.: To determine the frequency and types of medication used by older adults living in the Colombian capital, Bogota, and to identify the use of potentially inappropriate medications according to the revised Beers criteria. MATERIALS AND METHODS.: Data were obtained from the health, welfare, and aging (SABE, Spanish: salud, bienestar y envejecimiento) study conducted in both urban and rural areas of Bogota in 2012. The Mann-Whitney U test was used to analyze sex-related differences in the number of medications used among age-stratified subgroups. RESULTS.: Of 2 000 subjects, 1,268 (63.4%) were women; furthermore, 1,514 (75.7%) of the total participants had ≤5 years of basic education. The self-reported prevalence rates of hypertension and diabetes were 56.9% and 17.5%, respectively. The average number of medications per subject was 3.24, and it was higher in women (3.50) than in men (2.79). A total of 549 subjects (27.4%) reported using ≥5 medications. Only 311 subjects (15.6%) reported not using any medication. According to the Beers criteria, 443 (6.9%) of the medications were potentially inappropriate. CONCLUSIONS.: The use of inappropriate medications is a major problem among older adults in Bogota. Further studies should identify factors that increase the risks of polypharmacy and inappropriate medication use and design interventions that would allow older adults to avoid these risks.

Entities:  

Mesh:

Year:  2016        PMID: 27831603     DOI: 10.17843/rpmesp.2016.333.2292

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  1 in total

1.  Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study.

Authors:  Diego Arauna; Alvaro Cerda; José Francisco García-García; Sergio Wehinger; Felipe Castro; Diego Méndez; Marcelo Alarcón; Eduardo Fuentes; Iván Palomo
Journal:  Clin Interv Aging       Date:  2020-06-29       Impact factor: 4.458

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.